packageBelantamabMafodotin

belantamab mafodotin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Belantamab mafodotin, a monoclonal antibody drug conjugate, was used to treat multiple myeloma. It is no longer in use: its marketing authorisation in the European Union has expired, and it is listed as withdrawn.

Summary written by glm-5.3-flash from Wikidata Q98139657 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:belantamab mafodotin
ATC codes:L01FX15, L01XC39
DrugBank:DB15719
Wikidata:Q98139657

Metabolites

CysMcMMAFcys-mcMMAF1046.33 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
CysMcMMAFmetabolite: cys-mcMMAF